X0508 4 2025-09-10 0001635088 Roivant Sciences Ltd. ROIV 0001832142 Gold Daniel Allen C/O ROIVANT SCIENCES LTD. 7TH FLOOR, 50 BROADWAY LONDON X0 SW1H 0DB UNITED KINGDOM true false Common Shares 2025-09-10 4 A 0 14524 0 A 8971164 D Common Shares 2025-09-10 4 J 0 5270 13.77 D 8965894 D Stock Option (Right to Buy) 13.77 2025-09-10 4 A 0 33726 0 A 2035-09-09 Common Shares 33726 33726 D Reflects an annual award of restricted stock units with respect to Common Shares ("RSUs") granted pursuant to the Company's 2021 Equity Incentive Plan and the Company's Non-Employee Director Compensation Policy. The award of RSUs is scheduled to vest 100% on September 10, 2026, subject generally to the reporting person's continuous service through such date. Represents the "net settlement" by the Issuer of Common Shares previously granted to the reporting person pursuant to the Issuer's Non-Employee Director Compensation Plan in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of such Common Shares. Reflects an annual award of stock options to purchase Common Shares granted pursuant to the Company's 2021 Equity Incentive Plan and the Company's Non-Employee Director Compensation Policy. The award of stock options is scheduled to vest and become exercisable 100% on September 10, 2026, subject generally to the reporting person's continuous service through such date. By: /s/ Jo Chen, as Attorney-in-Fact for Daniel Gold 2025-09-12